Impact of the universal hepatitis B immunization program in Mongolia: Achievements and challenges

Journal of Epidemiology

Volumn 17, Issue 3, 2007, Pages 69-75

  Davaalkham, Dambadarjaa ^a   Ojima, Toshiyuki ^b   Uehara, Ritei ^a   Watanabe, Makoto ^a   Oki, Izumi ^a   Wiersma, Steven ^c   Nymadawa, Pagvajav ^d   Nakamura, Yosikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d National Center for Communicable Diseases   (Mongolia)

Author keywords

Effectiveness; Epidemiology; Hepatitis B virus; Immunization; Mongolia; Program

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CHILD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MONGOLIA; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH;

CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MONGOLIA; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; SEROEPIDEMIOLOGIC STUDIES;

EID: 34347389258     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.17.69     Document Type: Article

References (27)

1. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25(Suppl 1): 3-8.
2. Hepatitis B vaccines: WHO position paper. Weekly Epidemiological Record 2004; 79: 255-63.
3. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 992-1000.
4. Shiraki K. Perinatal transmission of hepatitis B virus and its prevention. J Gastroenterol Hepatol 2000; 15(Suppl): E11-E15.
5. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17: 1730-3.
6. Chang MH, Shan WY, Chen CJ, Wu TC, Kong MS, Liang DC, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000; 284: 3040-2.
7. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34: 1329-39.
8. Fujioka S, Shimomura H, Ishii Y, Kondo J, Fujio K, Ikeda F, et al. Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals. Kansenshogaku Zasshi 1998; 72: 5-11.
9. Takahashi M, Nishizawa T, Gotanda. Y, Tsuda F, Komatsu F, Kawabata T, et al. High prevalence of Antibodies to Hepatitis A and E viruses and Viremia of Hepatitis B, C, and D Viruses among Apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004; 11: 392-8.
10. National Center for Health Development, Ministry of Health of Mongolia. Annual Health Report-2004. Ulaanbaatar, 2004.
11. Davaalkham D, Ojima T, Nymadawa, P, Uehara R, Watanabe M, Oki I, et al. Prevalence and Risk Factors for Hepatitis C Virus Infection in Mongolian Children: Findings from a Nationwide Survey. J Med Virol 2006; 78:466-72.
12. Davaalkham D, Ojima T, Nymadawa P, Tsend N, Lkhagvasuren Ts, Wiersma S, et al. Seroepidemiology of Hepatitis B virus infection in Mongolian children: A Nationwide Survey. Pediatr Int 2007; 49 (in press).
13. National Statistical Office of Mongolia, United Nations Population. Fund, United Nations Statistics Division. 2000 Population and Housing Census: The main results. Ulaanbaatar, Mongolia, July 2001.
14. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135: 796-800.
15. Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program J Infect Dis 2000; 181: 413-8.
16. Poovorawan Y, Theamboonlers A, Vimolket T, Sinlaparatsamee S, Chaiear K, Siraprapasiri T, et al. Impact of hepatitis B immunization as part of the EPI. Vaccine 2000: 19; 943-9.
17. Adiyajav B, Alimaa D, Nymadawa P. Immunization of the Mongolian infants against Hepatitis B. Mongolian Medical Sciences 1995; 2: 33-8.
18. Dagwadorj Y, Davaasuren D, Gantuya S et al. Chronic HBV, HDV and HCV infection in Mongolian children. Switzerland, Basel. Liver Cirrhosis and its development 1999:78.
19. Davaalkham D, Ojima T, Wiersma S, Lkhagvasuren Ts, Nymadawa P, Uehara R, Watanabe M, Oki I, Takahashi M, Okamoto H, Nakamura Y. Administration of hepatitis B vaccine in winter as a significant predictor of poor vaccination effectiveness in rural Mongolia: Evidence from nationwide survey. J Epidemiol Community Health (in press).
20. Wilson N, Ruff TA, Rana BJ, Leydon J, Locarnini S. The effectiveness of the infant hepatitis B immunization program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine 2000; 18: 3059-66.
21. Edstam JS, Dulmaa N, Tsendjar O, Dambasuren B, Densmaa B. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med 2004; 39: 384-8.
22. Centers for Disease Control and Prevention. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Thr,ough Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991; 40(RR-13): 1-25.
23. Edstam. JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 2002: 34; 207-14.
24. Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40: 1415-20.
25. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, et al. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ 2002; 325: 569 (5 pages).
26. Yuen MF, Lim WL, Chan AO, Wong DK, Sum SS, Lai CL. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2004; 2: 941-5.
27. Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 2005; 24: 786-92.